Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 46Terminated 7Unknown 5Active not recruiting 3Recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Sarcoma 3Carcinoma, Renal Cell 2Vascular Neoplasms 1Solitary Fibrous Tumors 1Solid Tumor, Adult 1Solid Tumor 1Smooth Muscle Tumor 1Sarcoma, Clear Cell 1Rhabdomyosarcoma 1Recurrence 1Osteosarcoma 1Neurofibrosarcoma 1Nerve Sheath Neoplasms 1Neoplasms, Adipose Tissue 1Neoplasm Metastasis 1Myoepithelioma 1Liposarcoma, Myxoid 1Liposarcoma 1Kidney Neoplasms 1Histiocytoma, Angiomatoid Fibrous 1Hemangiosarcoma 1Hemangioendothelioma, Epithelioid 1Granuloma, Plasma Cell 1Granular Cell Tumor 1Glomus Tumor 1Fibrosarcoma 1Disorders of Sex Development 1Dermatofibrosarcoma 1Chondrosarcoma, Extraskeletal Myxoid 1

Interventions

Nivolumab 28pembrolizumab 24cabozantinib 22Ipilimumab 19Specimen Handling 14Magnetic Resonance Spectroscopy 13Axitinib 12lenvatinib 10Radiosurgery 9belzutifan 8CTLA-4 Antigen 7Biopsy 7atezolizumab 6cemiplimab 5Radiotherapy 5Bevacizumab 5toripalimab 4Everolimus 4Blood Specimen Collection 4avelumab 3aldesleukin 3X-Rays 3Sunitinib 3Standard of Care 3Paclitaxel 3zimberelimab 2trastuzumab deruxtecan 2tivozanib 2spartalizumab 2pazopanib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Renal Cell × pazopanib × Clear all
NCT06726421 2026-01-15

STROKER

Sun Yat-sen University

Phase 3 Recruiting
252 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT03592472 2025-04-13

A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

Xynomic Pharmaceuticals, Inc.

Phase 3 Recruiting
413 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡